Lv1
36 积分 2025-05-08 加入
GPNMB-directed CAR-T cell therapies for solid tumors
1个月前
已完结
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors
1个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结
The B7-H3 (CD276) pathway: emerging biology and clinical therapeutics
3个月前
已完结
Clinical progress of B7-H3 targeted antibody drug conjugate ifinatamab deruxtecan for small-cell lung cancer
3个月前
已完结
Simultaneous Affinity Maturation and Liability Removal from Antibodies
5个月前
已关闭
Geometric Antibody Engineering Reveals the Spatial Factor on the Efficacy of Bispecific T Cell Engagers
5个月前
已完结
Context-dependent synthetic lethality — an emerging precision therapeutic approach
5个月前
已完结
Influence of the Binding Valency of Anti-HER2 Biparatopic Antibodies on Biodistribution in an SK-OV-3 Tumor Xenograft Model
6个月前
已完结
A high-throughput selection system for fast-acting covalent protein drugs
6个月前
已完结
皖公网安备34019202002308
